Clinical Trial Update: Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma

View source ↗

Summary

This is a completed pilot clinical trial assessing biomarkers of response to immune checkpoint blockade in metastatic melanoma. The study aims to identify bioma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Immune checkpoint inhibitors (unspecified)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Melanoma | Status: COMPLETED